SL-279252
Phase 1CompletedDevelopment Stage
Squamous Cell Carcinoma of the Head and Neck
Squamous Cell Carcinoma of the Head and Neck, Melanoma, Non Small Cell Lung Cancer, Urothelial Carcinoma, Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma, Squamous Cell Carcinoma of the Anus, Squamous Cell Carcinoma of the Cervix, Squamous Cell Carcinoma of the Skin, Renal Cell Carcinoma, Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma, Mismatch Repair Deficient or MSI-High Solid Tumors
Mar 26, 2019 → May 4, 2023
About SL-279252
SL-279252 is a phase 1 stage product being developed by Shattuck Labs for Squamous Cell Carcinoma of the Head and Neck. The current trial status is completed. This product is registered under clinical trial identifier NCT03894618. Target conditions include Squamous Cell Carcinoma of the Head and Neck, Melanoma, Non Small Cell Lung Cancer.
Hype Score Breakdown
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT03894618 | Phase 1 | Completed |
Competing Products
20 competing products in Squamous Cell Carcinoma of the Head and Neck